For OTC derivatives, the pricing (still) isn’t right

Financial instrument expert Dirk Schubert on how post-GFC rules have caused prices and valuations to diverge


The 2008 G20 summit initiated regulatory changes aimed at stabilising the financial sector. Although firms are still implementing them, there is an opportunity to consider their impact on the prices and values of financial instruments.

Examining the interplay between pricing models can help determine the market prices of transactions owing to supply and demand; and the valuation models for financial instruments – those applied in front-office systems, risk management, performance measurement

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here